Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Pharmaceutical and Biopharmaceutical Safety Testing Service market size was valued at USD 3683.6 million in 2022 and is forecast to a readjusted size of USD 7743.3 million by 2029 with a CAGR of 11.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Biosafety testing is a series of assays to evaluate the potential biological risks of new biological products, including viral testing, microbial testing, cell and molecular testing, and analytic testing. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent testing to ensure the product is safe and free of contaminants.
This report is a detailed and comprehensive analysis for global Pharmaceutical and Biopharmaceutical Safety Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
The Primary Objectives in This Report Are:
This report profiles key players in the global Pharmaceutical and Biopharmaceutical Safety Testing Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Charles River Laboratories, Sartorius, Eurofins Scientific and SGS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical and Biopharmaceutical Safety Testing Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Market segment by Application
Market segment by players, this report covers
Market segment by regions, regional analysis covers
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical and Biopharmaceutical Safety Testing Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical and Biopharmaceutical Safety Testing Service, with revenue, gross margin and global market share of Pharmaceutical and Biopharmaceutical Safety Testing Service from 2018 to 2023.
Chapter 3, the Pharmaceutical and Biopharmaceutical Safety Testing Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical and Biopharmaceutical Safety Testing Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical and Biopharmaceutical Safety Testing Service.
Chapter 13, to describe Pharmaceutical and Biopharmaceutical Safety Testing Service research findings and conclusion.
Index
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical and Biopharmaceutical Safety Testing Service
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical and Biopharmaceutical Safety Testing Service by Type
1.3.1 Overview: Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value Market Share by Type in 2022
1.3.3 Raw Materials
1.3.4 Viral Banks
1.3.5 Cell Banks
1.3.6 Others
1.4 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market by Application
1.4.1 Overview: Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical and Biotechnology Companies
1.4.3 CROs and CDMOs
1.4.4 Academic and Research Institutions
1.5 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size & Forecast
1.6 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast by Region
1.6.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region, (2018-2029)
1.6.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Prospect (2018-2029)
1.6.6 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.1.4 Merck Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments and Future Plans
2.2 Charles River Laboratories
2.2.1 Charles River Laboratories Details
2.2.2 Charles River Laboratories Major Business
2.2.3 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.2.4 Charles River Laboratories Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Charles River Laboratories Recent Developments and Future Plans
2.3 Sartorius
2.3.1 Sartorius Details
2.3.2 Sartorius Major Business
2.3.3 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.3.4 Sartorius Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Sartorius Recent Developments and Future Plans
2.4 Eurofins Scientific
2.4.1 Eurofins Scientific Details
2.4.2 Eurofins Scientific Major Business
2.4.3 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.4.4 Eurofins Scientific Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eurofins Scientific Recent Developments and Future Plans
2.5 SGS
2.5.1 SGS Details
2.5.2 SGS Major Business
2.5.3 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.5.4 SGS Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 SGS Recent Developments and Future Plans
2.6 Q2 Solutions
2.6.1 Q2 Solutions Details
2.6.2 Q2 Solutions Major Business
2.6.3 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.6.4 Q2 Solutions Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Q2 Solutions Recent Developments and Future Plans
2.7 Samsung Biologics
2.7.1 Samsung Biologics Details
2.7.2 Samsung Biologics Major Business
2.7.3 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.7.4 Samsung Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Samsung Biologics Recent Developments and Future Plans
2.8 Texcell
2.8.1 Texcell Details
2.8.2 Texcell Major Business
2.8.3 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.8.4 Texcell Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Texcell Recent Developments and Future Plans
2.9 WuXi Biologics
2.9.1 WuXi Biologics Details
2.9.2 WuXi Biologics Major Business
2.9.3 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.9.4 WuXi Biologics Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 WuXi Biologics Recent Developments and Future Plans
2.10 Wuhan Canvest Biotechnology
2.10.1 Wuhan Canvest Biotechnology Details
2.10.2 Wuhan Canvest Biotechnology Major Business
2.10.3 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.10.4 Wuhan Canvest Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Canvest Biotechnology Recent Developments and Future Plans
2.11 Centre Testing International (CTI)
2.11.1 Centre Testing International (CTI) Details
2.11.2 Centre Testing International (CTI) Major Business
2.11.3 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.11.4 Centre Testing International (CTI) Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Centre Testing International (CTI) Recent Developments and Future Plans
2.12 Suzhou Liangchen Biotechnology
2.12.1 Suzhou Liangchen Biotechnology Details
2.12.2 Suzhou Liangchen Biotechnology Major Business
2.12.3 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.12.4 Suzhou Liangchen Biotechnology Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Suzhou Liangchen Biotechnology Recent Developments and Future Plans
2.13 JADE Biomedical
2.13.1 JADE Biomedical Details
2.13.2 JADE Biomedical Major Business
2.13.3 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.13.4 JADE Biomedical Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 JADE Biomedical Recent Developments and Future Plans
2.14 Standard Testing Group
2.14.1 Standard Testing Group Details
2.14.2 Standard Testing Group Major Business
2.14.3 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.14.4 Standard Testing Group Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Standard Testing Group Recent Developments and Future Plans
2.15 Sino Tech World Biologicals
2.15.1 Sino Tech World Biologicals Details
2.15.2 Sino Tech World Biologicals Major Business
2.15.3 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.15.4 Sino Tech World Biologicals Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Sino Tech World Biologicals Recent Developments and Future Plans
2.16 CAS Testing Technical Services
2.16.1 CAS Testing Technical Services Details
2.16.2 CAS Testing Technical Services Major Business
2.16.3 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.16.4 CAS Testing Technical Services Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 CAS Testing Technical Services Recent Developments and Future Plans
2.17 NTEK
2.17.1 NTEK Details
2.17.2 NTEK Major Business
2.17.3 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.17.4 NTEK Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 NTEK Recent Developments and Future Plans
2.18 Sino Biological
2.18.1 Sino Biological Details
2.18.2 Sino Biological Major Business
2.18.3 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.18.4 Sino Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Sino Biological Recent Developments and Future Plans
2.19 Miracle Points
2.19.1 Miracle Points Details
2.19.2 Miracle Points Major Business
2.19.3 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.19.4 Miracle Points Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Miracle Points Recent Developments and Future Plans
2.20 Suzhou Cefety Bioscience
2.20.1 Suzhou Cefety Bioscience Details
2.20.2 Suzhou Cefety Bioscience Major Business
2.20.3 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.20.4 Suzhou Cefety Bioscience Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Suzhou Cefety Bioscience Recent Developments and Future Plans
2.21 Zhejiang Hengyu Biological
2.21.1 Zhejiang Hengyu Biological Details
2.21.2 Zhejiang Hengyu Biological Major Business
2.21.3 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Product and Solutions
2.21.4 Zhejiang Hengyu Biological Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Zhejiang Hengyu Biological Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmaceutical and Biopharmaceutical Safety Testing Service by Company Revenue
3.2.2 Top 3 Pharmaceutical and Biopharmaceutical Safety Testing Service Players Market Share in 2022
3.2.3 Top 6 Pharmaceutical and Biopharmaceutical Safety Testing Service Players Market Share in 2022
3.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Market: Region Footprint
3.3.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market: Company Product Type Footprint
3.3.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Forecast by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Type (2018-2029)
6.2 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Application (2018-2029)
6.3 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
6.3.1 North America Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Country (2018-2029)
6.3.2 United States Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Type (2018-2029)
7.2 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Application (2018-2029)
7.3 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
7.3.1 Europe Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
7.3.3 France Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Region (2018-2029)
8.3.2 China Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
8.3.5 India Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
9 South America
9.1 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Type (2018-2029)
9.2 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Application (2018-2029)
9.3 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
9.3.1 South America Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical and Biopharmaceutical Safety Testing Service Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmaceutical and Biopharmaceutical Safety Testing Service Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Drivers
11.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Market Restraints
11.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Pharmaceutical and Biopharmaceutical Safety Testing Service Industry Chain
12.2 Pharmaceutical and Biopharmaceutical Safety Testing Service Upstream Analysis
12.3 Pharmaceutical and Biopharmaceutical Safety Testing Service Midstream Analysis
12.4 Pharmaceutical and Biopharmaceutical Safety Testing Service Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Published By : GlobalInfoResearch